Construction of anti-HER2 affibody-directed CAR-NK and its synergistic effects with doxorubicin-loaded nanodrug against HER2-positive breast cancer. - He X; Liang Z; Liu Q; Zhang X; Liang H; Jia R; Sheng W (Frontiers in immunology, 2026)